Compare ZBH & IFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZBH | IFF |
|---|---|---|
| Founded | 1927 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9B | 19.6B |
| IPO Year | N/A | N/A |
| Metric | ZBH | IFF |
|---|---|---|
| Price | $94.41 | $67.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 15 |
| Target Price | ★ $108.56 | $85.15 |
| AVG Volume (30 Days) | 2.1M | ★ 2.3M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | 1.02% | ★ 2.38% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.03 | N/A |
| Revenue | $8,010,900,000.00 | ★ $11,072,000,000.00 |
| Revenue This Year | $8.20 | N/A |
| Revenue Next Year | $5.92 | N/A |
| P/E Ratio | $23.38 | ★ N/A |
| Revenue Growth | ★ 5.47 | N/A |
| 52 Week Low | $85.33 | $59.14 |
| 52 Week High | $114.44 | $90.64 |
| Indicator | ZBH | IFF |
|---|---|---|
| Relative Strength Index (RSI) | 49.85 | 53.84 |
| Support Level | $92.14 | $66.04 |
| Resistance Level | $98.34 | $70.10 |
| Average True Range (ATR) | 1.99 | 1.60 |
| MACD | 0.49 | -0.10 |
| Stochastic Oscillator | 58.27 | 51.96 |
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients.